This, together with the near absence of homozygous KMT2D inactivating mutations in medulloblastoma [16], led us to speculate that the role of the KMT2D deficiency in cancer is more complicated than simply driving tumor cell proliferation. The gene discussed is KMT2D; the disease is medulloblastoma.